LEYMAN BARBARA (Chief Business Dev. Officer) exercised options at SUTRO BIOPHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/26/2025ACC: 0001415889-25-023084
Officer· Chief Business Dev. Officer
Since Jul 2024
-8.94K
Net shares
Net seller
$7.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
25K acquired · 33.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
New position
7/8/2025
0.00→25K
Common Stock
Direct
Shares
−8.94K
Price / share
$0.78
Trade value
$6.98K
% of position
35.8%
7/8/2025
25K→16.06K
Total
Net shares
+16.06K
Net value
-$6.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2025 | M · Option Exercise | +25K | — | — | New position | 0.00 | 25K |
| Common Stock Direct | 7/8/2025 | F · Tax Withholding | −8.94K | $0.78 | $6.98K | 35.8% | 25K | 16.06K |
| Total | +16.06K | -$6.98K | ||||||
Derivative Transactions1
Restricted Stock Units (RSUs)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
Held after
75K
Exercisable
—
7/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs) Direct | Common Stock25K shares | 7/8/2025 | M · Option Exercise | −25K | — | 75K |